This HTML5 document contains 205 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1093/NAR/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q39723434
rdf:type
wikibase:Item
schema:description
1998年论文 научна статия 1998年论文 1998年論文 1998年論文 vetenskaplig artikel artikulong pang-agham scienca artikolo এপ্রিল ১৯৯৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ наукова стаття, опублікована у квітні 1998 vědecký článek naučni članak bilimsel makale artikel ilmiah artigo científico επιστημονικό άρθρο videnskabelig artikel מאמר מדעי tieteellinen artikkeli 1998 nî lūn-bûn teaduslik artikkel articolo scientifico научни чланак wetenschappelijk artikel article científic artigo científico 1998年论文 научни чланак 1998年論文 1998年论文 article scientific vedecký článok scientific article published on April 1998 artikull shkencor 1998年の論文 vitskapeleg artikkel სამეცნიერო სტატია научная статья 1998年论文 articol științific artículo científico publicado en 1998 wissenschaftlicher Artikel scientific article published on April 1998 artigo científico vitenskapelig artikkel บทความทางวิทยาศาสตร์ 1998年论文 bài báo khoa học мақолаи илмӣ 1998년 논문 artykuł naukowy artículu científicu espublizáu en 1998 article scientifique 1998年論文 1998年論文 مقالة علمية نشرت في أبريل 1998 tudományos cikk scientific article published on April 1998
p:P577
wds:Q39723434-0D4859C9-9721-4232-A093-B866C1CC37FB
wdt:P577
1998-04-01T00:00:00Z
p:P407
wds:Q39723434-57CEAA43-B978-4A9D-9A31-8B9853103B66
wdt:P407
wd:Q1860
p:P2860
wds:Q39723434-1BF990EF-43C1-4D80-A398-62F4CCD45DC9 wds:Q39723434-20A63F29-1FED-4EE3-961D-AC11FF0B66A2 wds:Q39723434-0C3269CE-8883-4600-A1A7-C79D5E072DE4 wds:Q39723434-198A17F4-A1D3-4644-866A-B3691BE3E30C wds:Q39723434-286986B4-F1A9-4433-A3F7-08F708D218B3 wds:Q39723434-2A0E735F-83E5-415E-819E-A41C0BDB1CC3 wds:Q39723434-2B15D74F-A8BC-4F2A-9D2E-FC4B5F802BDD wds:Q39723434-235175BA-F221-4B68-B382-D647DBB727E9 wds:Q39723434-245CE1A6-BE24-45F3-92D5-9E44CAAAA6AE wds:Q39723434-2676F68C-6768-4E06-A316-98119A213800 wds:Q39723434-B7CC5964-6318-475B-8EC3-5E4DAD4E9B43 wds:Q39723434-B9E9D53C-B595-40B0-B145-0DB982338148 wds:Q39723434-C2803777-3543-4187-A8EB-C77DE7A971A4 wds:Q39723434-C9CC71C7-2E1C-4462-9E79-2E8BB65EF7A9 wds:Q39723434-A7738CF4-0A27-4D51-8084-27655331C221 wds:Q39723434-DEFE05A5-CFC4-49EE-9AD7-6933B64D6436 wds:Q39723434-E391F48B-EF8C-429D-80DB-1B41D10F8C14 wds:Q39723434-E6EBF2A8-961C-4800-A2B5-6C12D34EE52C wds:Q39723434-F0E30480-3B12-4E92-A61D-5B5E0732E9B8 wds:Q39723434-D14A2238-D351-4368-9C02-47C41E5F3245 wds:Q39723434-D1A6700D-40B9-4E60-A206-F68E5E90BAF1 wds:Q39723434-D4B0D19F-1CA3-41F6-A4F7-8E3E615F138A wds:Q39723434-D5E9DE03-6601-4B8B-8651-0DCFA3BEA766 wds:Q39723434-FED7EEBD-C22B-44C9-A71A-A4CC456552CB wds:Q39723434-F234ADC1-EE0A-4A0F-BDC4-ADDE34057E8B wds:Q39723434-F4BB5DB4-093A-4ED1-A582-78A55147BEB7 wds:Q39723434-F775C2B4-763B-4413-8A6B-F2F64252B3DA wds:Q39723434-5086BA2B-4F5E-43B1-8E5E-D6A5B50F9613 wds:Q39723434-55E55E56-6542-4A3B-8433-672DD874CB0E wds:Q39723434-2C5A2020-CD39-4195-BED3-5EC1EF75C323 wds:Q39723434-69E6045F-ADD7-49A9-B55B-46BEB9B39063 wds:Q39723434-6B532D7D-3CB8-4ED6-9788-A97A4EA7FB30 wds:Q39723434-768AF128-C1BC-4C07-9978-5899410230F6 wds:Q39723434-76F0596D-9418-457C-9744-B7BC05C5B47E wds:Q39723434-5D91B27B-DE9C-4E2F-B150-56C6CA895467 wds:Q39723434-5F9411D7-8EF7-45AA-96D4-C11F07D65010 wds:Q39723434-69DD5F37-358F-4450-B85C-0FBFBC5110E3 wds:Q39723434-8D22FE6A-DA3E-4C59-8A59-2380E27198D1 wds:Q39723434-8E9BC5E5-BFAD-4B04-8B83-C30BCA81FBC7 wds:Q39723434-952DC4C7-9843-4480-94B4-717178112E4E wds:Q39723434-95BE7169-DF63-448C-955A-D1C0B72A8698 wds:Q39723434-8269C77D-A247-456F-94B7-2741FDEE8802 wds:Q39723434-8A6DA711-2C53-4B9F-9C5A-C63B80BEA84E wds:Q39723434-8AF5D517-7B56-486C-9EA9-8BBCB102B97D wds:Q39723434-9DC42A75-2C87-418A-8487-595918AD5E3E wds:Q39723434-9E63A375-C1E0-4728-8EE2-32524C2089F5 wds:Q39723434-9FF2F031-20A7-4559-9CCA-68CBF7DDF03B wds:Q39723434-A5F5D944-6CCA-4B81-B0F7-5D97DF509590 wds:Q39723434-982E4909-6CBA-4E30-B0CA-A8C60721827A wds:Q39723434-98F4FF04-BB91-4B1A-8E8A-9F2E238EEC86
wdt:P2860
wd:Q27480411 wd:Q41173313 wd:Q44405547 wd:Q40524566 wd:Q73717207 wd:Q41985238 wd:Q44401543 wd:Q34250343 wd:Q41192006 wd:Q41403481 wd:Q28265748 wd:Q42122750 wd:Q41908017 wd:Q40393427 wd:Q72734057 wd:Q40420208 wd:Q38322598 wd:Q41390328 wd:Q41400619 wd:Q38355679 wd:Q45255391 wd:Q40898149 wd:Q41548206 wd:Q38332851 wd:Q28285221 wd:Q33855658 wd:Q71789430 wd:Q46040871 wd:Q41474207 wd:Q40995498 wd:Q40490717 wd:Q40394334 wd:Q46679436 wd:Q25938986 wd:Q33198210 wd:Q41496513 wd:Q38296465 wd:Q54167647 wd:Q38317588 wd:Q36000544 wd:Q41940139 wd:Q72966055 wd:Q29616154 wd:Q70121663 wd:Q34206916 wd:Q35858474 wd:Q46002868 wd:Q72727674 wd:Q41421601 wd:Q36754538
p:P2093
wds:Q39723434-1B886719-2532-43D8-9F2A-E43064298911 wds:Q39723434-235E8088-9ED0-4FC5-B514-DD58639AF168 wds:Q39723434-9B44ECAF-0A52-4874-8BEA-8E6054DA3074 wds:Q39723434-9D655277-1FA7-4149-9C98-C17DDBBE7F6D wds:Q39723434-3DDD3A59-0364-4AF3-AFAC-BBBDBCA3CF8A
wdt:P2093
Tidd DM Giles RV Nicklin P Clark RE Grzybowski J
rdfs:label
Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells
skos:prefLabel
Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells
schema:name
Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells
p:P50
wds:Q39723434-4426DEE3-1548-41C5-B24D-BC72741BCE62
wdt:P50
wd:Q37379472
p:P1476
wds:Q39723434-4BD14D10-9FBC-45E0-94CB-BABE1DC6EFC3
wdt:P1476
Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells
p:P304
wds:Q39723434-205B7871-24C2-438E-8FB6-A866211EFD0E
wdt:P304
1567-1575
p:P31
wds:Q39723434-2C47A0BC-E7E5-4416-B314-2DBA28D8AFA5
wdt:P31
wd:Q13442814
p:P921
wds:Q39723434-FDA70E71-6A3F-4FC5-8A00-4F5BCDE66CA1
wdt:P921
wd:Q29496
p:P698
wds:Q39723434-B392F07F-822F-4E10-96F1-30BC1D1C2C08
wdtn:P698
n8:9512525
wdt:P698
9512525
p:P1433
wds:Q39723434-B186B891-B5FA-45A6-A2DE-DC5CB866337E
wdt:P1433
wd:Q135122
p:P433
wds:Q39723434-87EE9A81-7B95-406D-8351-0F5DF63B53DF
p:P478
wds:Q39723434-0D2FFDDB-A1AF-4AE7-B00A-9C961F95FA09
wdt:P433
7
wdt:P478
26
p:P356
wds:Q39723434-5DA2CDDB-EF17-44D0-B7DE-D291763D1CC8
wdtn:P356
n9:26.7.1567
wdt:P356
10.1093/NAR/26.7.1567
p:P5875
wds:Q39723434-3EE9FCBD-6DC2-40B0-8618-FADEBDFCE9B1
wdt:P5875
51309124
p:P932
wds:Q39723434-A79670D9-6757-46B2-AB19-5A8116609514
wdt:P932
147466